So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the Misuse of Drugs to “carefully consider” the issue. Do you think ketamine should count as a Class A drug? Vote on our poll to tell us how how feel about this issue.

A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous narcotics operation spanning two boroughs.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year than those who reported no past-year drug use.

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what they've said

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term complications.

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental health conditions. However, they may cover the FDA-approved nasal spray, Spravato, which contains a derivative of ketamine called esketamine.

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray,

The Lamb of God frontman called the tech billionaire a "complete asshole." Randy Blythe Rips Elon Musk: He’s President Trump’s “Ketamine-Fueled Pet Rocket Monkey”

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.

They've found recreational use has grown dramatically over the past decade. It increased more than 80 percent from 2015 to 2019 and another 40 percent from 2021 to 2022. For experts, those numbers are alarming because the people consuming the drug may not know the serious risks associated with unsupervised use.